Innovative AI Platform Deep Genomics is leveraging cutting-edge artificial intelligence technology, including foundation models like BigRNA, to discover and develop genetic therapies. This positions the company as a leader in biotech innovation, providing opportunities to collaborate or integrate with advanced AI solutions in healthcare.
Expanding Therapeutic Capabilities Recent launches of RNA-focused models demonstrate Deep Genomics' commitment to pioneering treatments for RNA-related diseases. This opens avenues for partners in pharmaceutical R&D, gene therapy, and personalized medicine markets seeking advanced biotech AI tools.
Robust Financial Backing With over 761 million USD in funding and revenue between 10 and 25 million USD, Deep Genomics has considerable resources to invest in innovative collaborations, licensing deals, or joint ventures within the genomic medicine space.
$1M$10M
$1M$10M
$25M$50M
$1M$10M
$1M$10M
$1M
$25M$50MDeep Genomics uses 8 technology products and services including Kubeflow, Zendesk, TensorFlow, and more. Explore Deep Genomics's tech stack below.
| Deep Genomics Email Formats | Percentage |
| First@deepgenomics.com | 80% |
| First.Last@deepgenomics.com | 14% |
| Last@deepgenomics.com | 6% |
Biotechnology ResearchToronto, Canada51-200 Employees
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Company Overview
Media & News
Funding & FinancialsDeep Genomics has raised a total of $761M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180Mas a Series C.
Deep Genomics's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsDeep Genomics has raised a total of $761M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180Mas a Series C.
Deep Genomics's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com